Asymmetric Growth Playbook
The playbook describes the decision framework used for the AG sleeve within Portfolio Engineers and is presented for research transparency rather than as investment advice or trading instructions.
AG is not simply a collection of high-growth companies. It is a structured framework for pursuing asymmetric outcomes while controlling portfolio-level risk through sizing discipline, thesis validation, rebalancing, and survivability guardrails.
Position sizing, entries, scaling decisions, rebalancing, thesis review, and risk containment.
It does not eliminate volatility, predict every cycle, or prevent temporary underperformance.
Composition shows the holdings. Backtests show behavior. The playbook explains how decisions are made.
The governing logic
These principles define how AG is intended to behave as a sleeve. They are constraints designed to keep upside-seeking behavior from drifting into unmanaged speculation.
AG exists to pursue nonlinear winners while intentionally containing the capital at risk in any single thesis, theme, or cycle.
Positions are evaluated based on whether they serve a clear role: platform leadership, infrastructure leverage, or exposure to a credible secular theme.
AG is expected to look wrong at times. The objective is not smoothness. The objective is disciplined exposure to asymmetric outcomes.
Many asymmetric outcomes require time to develop. AG assumes that volatility and temporary underperformance can be natural consequences of pursuing long-duration innovation.
If a hypothetical severe drawdown would materially compromise the total portfolio’s long-term plan, sizing and concentration controls are the first variables to revisit.
How a position moves through the system
A useful way to understand AG is to view it as a repeatable lifecycle. The playbook is not a prediction engine. It is a decision framework.
Start with the structural reason the business matters: platform economics, an infrastructure bottleneck, category leadership, or a secular demand wave.
Position size reflects uncertainty, volatility, and role in the sleeve. Higher uncertainty typically earns smaller weight and more proof before scaling.
Each thesis should have explicit validation signals such as operational traction, revenue growth, adoption metrics, backlog quality, or evidence of durable competitive advantage.
Price alone is not a thesis. The playbook reviews business progress, competitive position, and position weight before considering changes.
This sleeve is designed to let ideas earn more capital over time. It does not assume conviction at purchase is the same thing as proof.
What earns a place in AG
New ideas are typically evaluated on strategic role, a credible asymmetry case, and a position size appropriate to uncertainty.
New positions are typically evaluated based on whether they fill a defined role: core compounder, early disruptor, infrastructure enabler, or theme-specific optionality.
The framework does not rely on perfect visibility. It prioritizes upside that is meaningfully larger than the capital allocated to the idea within a defined risk budget.
Unproven ideas begin small. Scaling is earned through execution signals over time, not enthusiasm.
What can justify reduction or removal
Reductions or exits are typically considered when thesis quality degrades, silent risk drift emerges, or opportunity cost improves elsewhere within the same risk budget, not merely because a chart feels uncomfortable.
Reductions or exits are typically considered when the original reason for owning the business weakens, stalls, or proves structurally wrong.
Winners can become oversized. Rebalancing helps prevent a single name from quietly rewriting the sleeve’s risk profile.
Capital may rotate when a holding remains acceptable, but incremental upside elsewhere is more compelling within the same risk constraints.
Rules that protect the sleeve from itself
These are constraints designed to keep AG aligned with the total portfolio. Without them, upside-seeking can drift into sizing creep, narrative concentration, and unstructured risk.
AG is a controlled sleeve, not the entire portfolio. Its job is to add upside, not to become the portfolio’s only identity.
No single position should be large enough that an extreme drawdown (e.g., 80%) would compromise the portfolio’s long-term plan.
Convex exposure is distributed across distinct engines of upside rather than unintentionally concentrating exposure in a single narrative or technology cycle.
Rebalancing exists to preserve optionality, harvest drift, and prevent emotional attachment from becoming allocation policy.
How AG is maintained over time
The sleeve is reviewed on a consistent cadence so that decisions come from a process rather than a burst of emotion.
Regular reviews reassess thesis progress, position size drift, business execution, and whether each name still deserves capital within the sleeve.
Major earnings changes, guidance breaks, dilution, competitive disruption, or structural business changes can justify an immediate reassessment.
Rapid appreciation can cause a position to dominate the sleeve. Periodic rebalancing helps maintain diversification and preserve optionality.
AG is reviewed as a whole: concentration, theme balance, overlap, and whether expected volatility still fits the total portfolio.
AG only works if the sleeve remains intentional
The role of the playbook is to preserve asymmetry while reducing avoidable self-inflicted errors. It provides a framework for adding, validating, trimming, and rotating without relying on impulse.